Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells

Japanese Journal of Cancer Research

Volumn 93, Issue 12, 2002, Pages 1317-1326

  Matsumoto, Joe ^a,b   Kaneda, Masako ^a,b   Tada, Mitsuhiro ^a   Hamada, Jun Ichi ^a   Okushiba, Shunichi ^b   Kondo, Satoshi ^b   Katoh, Hiroyuki ^b   Moriuchi, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Akt protein kinase B; Constitutive activation; K ras; Pancreatic cancer; PTEN

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COMPLEMENTARY DNA; GENISTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; SYNAPTOPHYSIN;

APOPTOSIS; CANCER CELL CULTURE; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA DETERMINATION; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; WILD TYPE;

EID: 0036949812     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01240.x     Document Type: Review

References (61)

1. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y. and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241 (1997).
2. Romashkova, J. A. and Makarov, S. S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature, 401, 86-90 (1999).
3. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868 (1999).
4. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S. and Reed, J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321 (1998).
5. Cheng, J. Q., Altomare, D. A., Klein, M. A., Lee, W. C., Kruh, G. D., Lissy, N. A. and Testa, J. R. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene, 14, 2793-2801 (1997).
6. Medema, R. H., Kops, G. J., Bos, J. L. and Burgering, B. M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404, 782-787 (2000).
7. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W. and Semenza, G. L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res., 60, 1541-1545 (2000).
8. Stambolic, V., Suzuki, A., Delapompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P. and Mak, T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39 (1998).
9. Otsu, M., Hiles, I., Gout, I., Fry, M. J., Ruiz-Larrea, F., Panayotou, G., Thompson, A., Dhand, R., Hsuan, J., Totty, N., Courtneidge, S. and Waterfield, M. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell, 65, 91-104 (1991).
10. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature, 370, 527-532 (1994).
11. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95, 13513-13518 (1998).
12. Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G. and Stokoe, D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol., 8, 1195-1198 (1998).
13. Zhang, C. L., Tada, M., Kobayashi, H., Nozaki, M., Moriuchi, T. and Abe, H. Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay. Oncogene, 19, 4346-4353 (2000).
14. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940 (1997).
15. Tsao, H., Zhang, X., Fowlkes, K. and Haluska, F. G. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res., 60, 1800-1804 (2000).
16. Dahia, P. L., Marsh, D. J., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R., Longy, M., Larsson, C. and Eng, C. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res., 57, 4710-4713 (1997).
17. Ruggeri, B. A., Huang, L., Wood, M., Cheng, J. Q. and Testa, J. R. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol. Carcinog., 21, 81-86 (1998).
18. Hu, Q., Klippel, A., Muslin, A. J., Fanti, W. J. and Williams, L. T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science, 268, 100-102 (1995).
19. Marte, B. M., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. and Downward, J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr. Biol., 7, 63-70 (1997).
20. Tolias, K. F., Cantley, L. C. and Carpenter, C. L. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem., 270, 17656-17659 (1995).
21. Lee, S. W., Fang, L., Igarashi, M., Ouchi, T., Lu, K. P. and Aaronson, S. A. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA, 97, 8302-8305 (2000).
22. Fang, L., Li, G., Liu, G., Lee, S. W. and Aaronson, S. A. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and P13K/Akt signaling cascades. EMBO J., 20, 1931-1939 (2001).
23. Flaman, J.-M., Frebourg, T., Moreau, V., Charbonnier, F., Martin, C., Chappuis, P., Sappino, A.-P., Limacher, J.-M., Brons, L., Benhattar, J., Tada, M., Van Meir, E. G., Estreicher, A. and Iggo, R. D. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. USA, 92, 3963-3967 (1995).
24. Kashiwazaki, H., Tonoki, H., Tada, M., Chiba, I., Shindoh, M., Totsuka, Y., Iggo, R. and Moriuchi, T. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene, 15, 2667-2674 (1997).
25. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K. and Testa, J. R. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA, 93, 3636-3641 (1996).
26. Gire, V., Marshall, C. and Wynford-Thomas, D. PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS. Oncogene, 19, 2269-2276 (2000).
27. Moodie, S. A. and Wolfman, A. The 3Rs of life: Ras, Raf and growth regulation. Trends Genet., 10, 44-48 (1994).
28. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269, 5241-5248 (1994).
29. Lemoine, N. R., Hughes, C. M., Barton, C. M., Poulsom, R., Jeffery, R. E., Kloppel, G., Hall, P. A. and Gullick, W. J. The epidermal growth factor receptor in human pancreatic cancer. J. Pathol., 166, 7-12 (1992).
30. Barton, C. M., Hall, P. A., Hughes, C. M., Gullick, W. J. and Lemoine, N. R. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J. Pathol., 163, 111-116 (1991).
31. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592-5595 (1987).
32. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15, 6541-6551 (1996).
33. Bellacosa, A., Chan, T. O., Ahmed, N. N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J. and Tsichlis, P. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene, 17, 313-325 (1998).
34. Yip-Schneider, M. T., Lin, A. and Marshall, M. S. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem. Biophys. Res. Commun., 280, 992-997 (2001).
35. Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E. and Fuller, G. N. Combined activation of ras and akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 25, 55-57 (2000).
36. Tolkacheva, T. and Chan, A. M. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene. Oncogene, 19, 680-689 (2000).
37. Yan, J., Roy, S., Apolloni, A., Lane, A. and Hancock, J. F. Ras isoforms vary in their ability to activate Raf-1 and phosphonoisitide 3-kinase. J. Biol. Chem., 273, 24052-24056 (1998).
38. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689 (1989).
39. Przybojewska, B., Jagiello, A. and Jalmuzna, P. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet. Cytogenet., 121, 73-77 (2000).
40. Nguyen, K. T., Wang, W. J., Chan, J. L. and Wang, L. H. Differential requirements of the MAP kinase and P13 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells. Oncogene, 19, 5385-5397 (2000).
41. Penuel, E. and Martin, G. S. Transformation by v-Src: Ras-MAPK and P13K-mTOR mediate parallel pathways. Mol. Biol. Cell, 10, 1693-1703 (1999).
42. Zimmermann, S. and Moelling, K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science, 286, 1741-1744 (1999).
43. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 385, 544-548 (1997).
44. Wick, M. J., Dong, L. Q., Riojas, R. A., Ramos, F. J. and Liu, F. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1. J. Biol. Chem., 275, 40400-40406 (2000).
45. Shao, J., Sheng, H. and DuBois, R. N. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res., 62, 3282-3288 (2002).
46. Hock, B., Bohme, B., Karn, T., Yamamoto, T., Kaibuchi, K., Holtrich, U., Holland, S., Pawson, T., Rubsamen-Waigmann, H. and Strebhardt, K. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc. Natl. Acad. Sci. USA, 95, 9779-9784 (1998).
47. Clark, G. J., Kinch, M. S., Rogers-Graham, K., Sebti, S. M., Hamilton, A. D. and Der, C. J. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J. Biol. Chem., 272, 10608-10615 (1997).
48. Du, K. and Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem., 273, 32377-32379 (1998).
49. Miknyoczki, S. J., Lang, D., Huang, L., Klein-Szanto, A. J., Dionne, C. A. and Ruggeri, B. A. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int. J. Cancer, 81, 417-427 (1999).
50. Qian, X., Esteban, L., Vass, W. C., Upadhyaya, C., Papageorge, A. G., Yienger, K., Ward, J. M., Lowy, D. R. and Santos, E. The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J., 19, 642-654 (2000).
51. de Kok, A. J., Sips, H., Chang, G. T. and Verheijen, J. H. Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c-Ha-ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype. Carcinogenesis, 10, 1155-1161 (1989).
52. Diaz-Meco, M. T., Quinones, S., Municio, M. M., Sanz, L., Bernal, D., Cabrero, E., Saus, J. and Moscat, J. Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C. J. Biol. Chem., 266, 22597-22602 (1991).
53. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M. and Boyd, D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem., 271, 10672-10680 (1996).
54. Hurta, R. A. and Wright, J. A. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines. J. Cell. Physiol., 158, 187-197 (1994).
55. Futakawa, N., Kimura, W., Yamagata, S., Zhao, B., Ilsoo, H., Inoue, T., Sata, N., Kawaguchi, Y., Kubota, Y. and Muto, T. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer. J. Hepatobiliary Pancreat. Surg., 7, 63-71 (2000).
56. Sorio, C., Baron, A., Orlandini, S., Zamboni, G., Pederzoli, P., Huebner, K. and Scarpa, A. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res., 59, 1308-1314 (1999).
57. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G. and Pepper, M. S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes turnout metastasis. EMBO J., 20, 672-682 (2001).
58. Shimoyama, S., Gansauge, F., Gansauge, S., Widmaier, U., Oohara, T. and Beger, H. G. Overexpression of intercellular adhesion molecule-1 (ICAM-1) in pancreatic adenocarcinoma in comparison with normal pancreas. Pancreas, 14, 181-186 (1997).
59. Kamohara, H., Sakamoto, K., Ishiko, T., Mita, S., Masuda, Y., Abe, T. and Ogawa, M. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF). Res. Commun. Mol. Pathol. Pharmacol., 85, 131-140 (1994).
60. Ohba, Y., Mochizuki, N., Yamashita, S., Chan, A. M., Schrader, J. W., Hattori, S., Nagashima, K. and Matsuda, M. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J. Biol. Chem., 275, 20020-20026 (2000).
61. Beguinot, L., Werth, D., Ito, S., Richert, N., Willingham, M. C. and Pastan, I. Functional studies on the EGF receptor with an antibody that recognizes the intracellular portion of the receptor. J. Biol. Chem., 261, 1801-1807 (1986).